JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Total Liabilities
Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has total liabilities worth Rs8.09 Billion INR (≈ $87.54 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of JB Chemicals & Pharmaceuticals Limited to track the company's year-over-year net asset growth rate.
JB Chemicals & Pharmaceuticals Limited - Total Liabilities Trend (2005–2026)
This chart illustrates how JB Chemicals & Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. See JBCHEPHARM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
JB Chemicals & Pharmaceuticals Limited Competitors by Total Liabilities
The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
De Grey Mining Ltd
AU:DEG
|
Australia | AU$33.89 Million |
|
Companhia Energética de Minas Gerais
F:CID
|
Germany | €38.45 Billion |
|
Silgan Holdings Inc
NYSE:SLGN
|
USA | $7.00 Billion |
|
SiteOne Landscape Supply Inc
NYSE:SITE
|
USA | $1.81 Billion |
|
Vietnam Rubber Group Ltd
VN:GVR
|
Vietnam | ₫22.19 Trillion |
|
Tanger Factory Outlet Centers Inc
NYSE:SKT
|
USA | $2.14 Billion |
|
INTERCORP FIN.SERV. O.N.
F:9IFA
|
Germany | €86.68 Billion |
|
Pepkor Holdings Ltd
JSE:PPH
|
South Africa | ZAC51.80 Billion |
Liability Composition Analysis (2005–2026)
This chart breaks down JB Chemicals & Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is JB Chemicals & Pharmaceuticals Limited worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how JB Chemicals & Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for JB Chemicals & Pharmaceuticals Limited (2005–2026)
The table below shows the annual total liabilities of JB Chemicals & Pharmaceuticals Limited from 2005 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs8.09 Billion ≈ $87.54 Million |
-3.69% |
| 2025-03-31 | Rs8.40 Billion ≈ $90.89 Million |
-21.51% |
| 2024-03-31 | Rs10.71 Billion ≈ $115.80 Million |
-0.25% |
| 2023-03-31 | Rs10.74 Billion ≈ $116.10 Million |
+129.00% |
| 2022-03-31 | Rs4.69 Billion ≈ $50.70 Million |
+10.39% |
| 2021-03-31 | Rs4.25 Billion ≈ $45.93 Million |
+13.08% |
| 2020-03-31 | Rs3.76 Billion ≈ $40.62 Million |
+21.91% |
| 2019-03-31 | Rs3.08 Billion ≈ $33.32 Million |
-3.89% |
| 2018-03-31 | Rs3.21 Billion ≈ $34.67 Million |
+4.01% |
| 2017-03-31 | Rs3.08 Billion ≈ $33.33 Million |
-33.30% |
| 2016-03-31 | Rs4.62 Billion ≈ $49.97 Million |
-6.16% |
| 2015-03-31 | Rs4.92 Billion ≈ $53.25 Million |
+59.76% |
| 2014-03-31 | Rs3.08 Billion ≈ $33.33 Million |
+10.10% |
| 2013-03-31 | Rs2.80 Billion ≈ $30.27 Million |
+22.86% |
| 2012-03-31 | Rs2.28 Billion ≈ $24.64 Million |
-25.98% |
| 2011-03-31 | Rs3.08 Billion ≈ $33.29 Million |
+14.50% |
| 2010-03-31 | Rs2.69 Billion ≈ $29.08 Million |
-3.09% |
| 2009-03-31 | Rs2.77 Billion ≈ $30.00 Million |
-3.77% |
| 2008-03-31 | Rs2.88 Billion ≈ $31.18 Million |
-1.89% |
| 2007-03-31 | Rs2.94 Billion ≈ $31.78 Million |
+68.00% |
| 2006-03-31 | Rs1.75 Billion ≈ $18.91 Million |
+37.57% |
| 2005-03-31 | Rs1.27 Billion ≈ $13.75 Million |
-- |
About JB Chemicals & Pharmaceuticals Limited
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more